Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000544716 | SCV000640854 | benign | Nemaline myopathy 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003139774 | SCV003810337 | uncertain significance | not provided | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003403291 | SCV004122915 | uncertain significance | not specified | 2023-10-02 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000544716 | SCV001458315 | uncertain significance | Nemaline myopathy 2 | 2019-11-11 | no assertion criteria provided | clinical testing |